In vitro, CXCL1 stimulated the proliferation, invasion, and migration of breast cancer cells while inhibiting apoptosis, which seems to partially explain the unfavorable prognosis of patients with overexpression of this chemokine [18,32]. Here, CXCL1 is linked to breast carcinoma.